Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fricker

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Inorganic Chemistry|March 13, 1996
Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III)Richard V. Parish, Brian P. Howe, Jonathan P. Wright, et al.
Journal of Inorganic Biochemistry|April 13, 2011
Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activityYongbao Zhu, Beth R Cameron, Renee Mosi, et al.
The American Journal of Pathology|August 1, 2006
AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formationJerry S Hu, Christine M Freeman, Valerie R Stolberg, et al.
Bulletin Du Cancer|November 21, 2000
[Germ-line mutations of the BRCA1 gene in northeastern France]J P Fricker, D Muller, B Cutuli, et al.
Preventive Medicine|February 20, 2021
Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunize marginalized populationsSarah H Brown, Emilie L Fisher, Alexandra Q Taylor, et al.
Journal of Medicinal Chemistry|December 20, 1996
Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexesR G Buckley, A M Elsome, S P Fricker, et al.
British Journal of Cancer|March 30, 2013
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070G O'Boyle, I Swidenbank, H Marshall, et al.
British Journal of Pharmacology|January 8, 1998
Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseasesS P Fricker, E Slade, N A Powell, et al.
Journal of Cardiovascular Pharmacology|February 28, 2002
A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejectionGalen M Pieper, Allan M Roza, Mark B Adams, et al.
Nuclear Medicine and Biology|June 26, 1999
Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapyR C Brooks, P Carnochan, J F Vollano, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Inorganic Chemistry|March 13, 1996
Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III)Richard V. Parish, Brian P. Howe, Jonathan P. Wright, et al.
Journal of Inorganic Biochemistry|April 13, 2011
Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activityYongbao Zhu, Beth R Cameron, Renee Mosi, et al.
The American Journal of Pathology|August 1, 2006
AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formationJerry S Hu, Christine M Freeman, Valerie R Stolberg, et al.
Bulletin Du Cancer|November 21, 2000
[Germ-line mutations of the BRCA1 gene in northeastern France]J P Fricker, D Muller, B Cutuli, et al.
Preventive Medicine|February 20, 2021
Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunize marginalized populationsSarah H Brown, Emilie L Fisher, Alexandra Q Taylor, et al.
Journal of Medicinal Chemistry|December 20, 1996
Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexesR G Buckley, A M Elsome, S P Fricker, et al.
British Journal of Cancer|March 30, 2013
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070G O'Boyle, I Swidenbank, H Marshall, et al.
British Journal of Pharmacology|January 8, 1998
Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseasesS P Fricker, E Slade, N A Powell, et al.
Journal of Cardiovascular Pharmacology|February 28, 2002
A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejectionGalen M Pieper, Allan M Roza, Mark B Adams, et al.
Nuclear Medicine and Biology|June 26, 1999
Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapyR C Brooks, P Carnochan, J F Vollano, et al.
Pageof 15